This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
8 Dec 2017

‘Pre-Connecting’ on API issues, regulatory questions, emerging markets and biosimilars

What did you miss? Read an expert analysis of top, need-to-know information presented at this year’s CPHI Worldwide Pre-Connect Congress.

The day before CPHI Worldwide began in Frankfurt, Germany, this past October, several hundred people gathered for the day-long Pre-Connect Congress to learn, network, and gather insights on the pressing topics that impact pharma growth and development year-round.

In a new article, industry expert and CPHI Worldwide presenter Kate Kuhrt of Clarivate Analytics highlights some of the top, need-to-know information presented at this year’s Pre-Connect Congress – including trends in API sourcing and contract manufacturing, biosimilars, new regulations and regulatory compliance, and developments in emerging markets.

Her overview summarizes findings from key experts, including Pre-Connect keynote speaker Tae Han Kim, president and CEO of Samsung BioLogics, and Alan Sheppard, principal, global generics, thought leadership at IQVIA, formerly QuintilesIMS.

Kuhrt details findings from four Pre-Connect sessions:

• “Biologics: Growing industry with growing uncertainty” (CEO Keynote)

• “API sourcing and manufacturing update”

• “The future of generics”

• “Biosimilar update in the U.S. and Europe”

Mentioned Companies
Clarivate
View company profile